News tagged with oxaliplatin
Smoking worsens outcomes with advanced colon cancer
(HealthDay)—Smoking is tied to significantly shorter disease-free survival (DFS) and time to recurrence (TTR) in patients undergoing treatment for stage III colon cancer, according to a study published ...
Cancer
Apr 06, 2013 |
5 / 5 (1) |
2
Medication duloxetine helps reduce pain from chemotherapy
Among patients with painful chemotherapy-induced peripheral neuropathy, use of the anti-depressant drug duloxetine for 5 weeks resulted in a greater reduction in pain compared with placebo, according to a study in the April ...
Cancer
Apr 02, 2013 |
4 / 5 (1) |
0
Bevacizumab doesn't prolong survival in stage II-III colon CA
(HealthDay)—For patients with stage 2 to 3 colon cancer, the addition of bevacizumab to modified fluorouracil, leucovorin, and oxaliplatin (FOLFOX6) does not prolong disease-free or overall survival, according ...
Cancer
Dec 12, 2012 |
not rated yet |
0
New type of molecular switch could turn up the volume on bowel cancer treatment
(Medical Xpress)—A new type of molecular switch can boost common chemotherapy drugs to destroy bowel cancer cells, according to research presented today (Monday) at the NCRI Cancer Conference in Liverpool.
Cancer
Nov 05, 2012 |
4 / 5 (1) |
0
|
Bowel cancer 'chemo swap' shrinks tumours, making surgery safer and easier
Giving some bowel cancer patients six weeks of chemotherapy before surgery can significantly shrink their tumour, making it easier to remove and potentially reducing the chances of the cancer coming back, ...
Cancer
Nov 01, 2012 |
1 / 5 (1) |
0
Drug trial offers hope to patients with advanced colorectal cancer
A new drug treatment could offer hope to patients with advanced colorectal cancer who were intolerant of or did not respond to standard treatments, according to an article published in the Lancet Oncology.
Cancer
Aug 27, 2012 |
not rated yet |
0
No benefit seen for adjuvant oxaliplatin in stage II colon CA
(HealthDay) -- For elderly patients with colon cancer or those with stage II disease, the addition of oxaliplatin to fluorouracil with leucovorin (FL) does not seem to offer any survival benefit, according ...
Cancer
Aug 21, 2012 |
not rated yet |
0
Nonoperative approach feasible in advanced colon cancer
(HealthDay) -- Treating patients with surgically unresectable metastatic colon cancer and an asymptomatic intact primary tumor with bevacizumab and infusional fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) ...
Cancer
Aug 09, 2012 |
not rated yet |
0
Zaltrap approved for advanced colorectal cancer
(HealthDay) -- Zaltrap (ziv-afilbercept) has been approved by the U.S. Food and Drug Administration in combination with a FOLFIRI chemotherapy regimen for adults with advanced metastatic (spreading) colorectal cancer, the ...
Medications
Aug 04, 2012 |
not rated yet |
0
Induction chemo beneficial in locally advanced pancreatic CA
(HealthDay) -- For most patients with locally advanced pancreatic carcinoma (LAPC), induction with a combination of gemcitabine and oxaliplatin (GEMOX) followed by chemoradiotherapy (CRT) is feasible, resulting ...
Cancer
Jul 17, 2012 |
not rated yet |
0
ASCO: Continuing avastin with 2nd-line chemo ups survival
(HealthDay) -- Continuing use of bevacizumab (Avastin) in combination with second-line chemotherapy improves overall survival (OS) and progression-free survival (PFS) in patients with metastatic colorectal ...
Cancer
Jun 05, 2012 |
not rated yet |
0
Antidepressant helps relieve pain from chemotherapy, study finds
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful tingling feelings caused by chemotherapy in 59 percent of patients, a new study finds. This is the first clinical trial to find an ...
Cancer
Jun 04, 2012 |
not rated yet |
0
|
Many primary care docs don't know long-term effects of chemo: survey
(HealthDay) -- Many primary care doctors don't know the long-term side effects of the chemotherapy treatments that cancer survivors under their care may have been given, a new survey found.
Cancer
May 17, 2012 |
5 / 5 (2) |
1
Adding drug to chemotherapy following colon cancer surgery does not improve disease-free survival
Adding the drug cetuximab to a regimen of drugs used for the treatment of patients following surgery for stage III colon cancer did not result in improved disease-free survival, according to a study in the April 4 issue of ...
Cancer
Apr 03, 2012 |
not rated yet |
0
Balancing oxaliplatin dose with neurological side effects in metastatic colon cancer
The drug oxaliplatin is a major reason the prognosis for metastatic colon cancer has gone from an expected survival of several months to a couple years. Unfortunately, the drug can also carry with it debilitating neurological ...
Cancer
Feb 02, 2012 |
5 / 5 (1) |
0
Oxaliplatin
Oxaliplatin is a coordination complex that is used in cancer chemotherapy. These platinum-based drugs are usually classified as alkylating agents, although they are not actually alkylating groups (they function by a similar mechanism).
For more information about Oxaliplatin, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
